137 related articles for article (PubMed ID: 38546631)
1. Exogenous Estrogen in the Development of Head and Neck Cancer.
Doll C; Hofmann E; Preissner R; Heiland M; Seeland U; Konietschke F; Sehouli J; Preissner S
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):378-384. PubMed ID: 38546631
[TBL] [Abstract][Full Text] [Related]
2. Age at menopause and hormone replacement therapy as risk factors for head and neck and oesophageal cancer (Review).
McCarthy CE; Field JK; Marcus MW
Oncol Rep; 2017 Oct; 38(4):1915-1922. PubMed ID: 28765919
[TBL] [Abstract][Full Text] [Related]
3. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.
Wang S; Wang Y; Xu J; Chen Y
Medicine (Baltimore); 2017 Apr; 96(14):e6556. PubMed ID: 28383429
[TBL] [Abstract][Full Text] [Related]
4. Estrogens and the risk of complex regional pain syndrome (CRPS).
de Mos M; Huygen FJ; Stricker BH; Dieleman JP; Sturkenboom MC
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):44-52. PubMed ID: 19111016
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
[TBL] [Abstract][Full Text] [Related]
6. Hormone factors play a favorable role in female head and neck cancer risk.
Hashim D; Sartori S; La Vecchia C; Serraino D; Maso LD; Negri E; Smith E; Levi F; Boccia S; Cadoni G; Luu HN; Lee YA; Hashibe M; Boffetta P
Cancer Med; 2017 Aug; 6(8):1998-2007. PubMed ID: 28707400
[TBL] [Abstract][Full Text] [Related]
7. Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer.
McVicker L; Labeit AM; Coupland CAC; Hicks B; Hughes C; McMenamin Ú; McIntosh SA; Murchie P; Cardwell CR
JAMA Oncol; 2024 Jan; 10(1):103-108. PubMed ID: 37917089
[TBL] [Abstract][Full Text] [Related]
8. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
Tzingounis V; Cardamakis E; Ginopoulos P; Argiropoulos G
Anticancer Res; 1996; 16(6C):3997-4000. PubMed ID: 9042326
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
11. Reproductive factors, hormone use, and incidence of melanoma in a cohort of US Radiologic Technologists.
Mai JZ; Zhang R; Sargen MR; Little MP; Alexander BH; Tucker MA; Kitahara CM; Cahoon EK
Hum Reprod; 2022 May; 37(5):1059-1068. PubMed ID: 35174864
[TBL] [Abstract][Full Text] [Related]
12. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
14. The effects of oestrogen administration on the plasma free protein S and C4b-binding protein.
Melissari E; Kakkar VV
Thromb Res; 1988 Mar; 49(5):489-95. PubMed ID: 2967557
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk of Suicide Among Patients With Head and Neck Cancer in Rural, Urban, and Metropolitan Areas.
Osazuwa-Peters N; Barnes JM; Okafor SI; Taylor DB; Hussaini AS; Adjei Boakye E; Simpson MC; Graboyes EM; Lee WT
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1045-1052. PubMed ID: 34297790
[TBL] [Abstract][Full Text] [Related]
16. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
Khoo SK; Chick P
Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
[TBL] [Abstract][Full Text] [Related]
17. Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy.
Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
Melanoma Res; 2009 Oct; 19(5):327-32. PubMed ID: 19593232
[TBL] [Abstract][Full Text] [Related]
18. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
Lee JH; Ba D; Liu G; Leslie D; Zacharia BE; Goyal N
JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):339-344. PubMed ID: 30816930
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
